drugset / Trial / NCT00219544
Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will measure the impact of treatment with pregabalin in adult men and women who have a diagnosis of peripheral neuropathic pain (pain caused by a primary lesion of the peripheral nervous system such as Diabetic peripheral Neuropathy and Postherpetic Neuralgia).
Timeline
- Start
- 2005-11
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 150 mg | — |
| Subject | Pregabalin | Small molecule | 300 mg | — |
| Subject | Pregabalin | Small molecule | 600 mg | — |